Puretech founded entity seaport therapeutics announces the publication of new research demonstrating increased lymphatic transport with up to 55 percent drug absorption via lymphatics with glyphtm platform

Boston--(business wire)--puretech founded entity seaport therapeutics announces publication of new research demonstrating increased lymphatic transport with glyph platform.
PRTC Ratings Summary
PRTC Quant Ranking